ONS Partners with ASCO CancerLinQ to Launch CancerLinQ® Ambassadors Program

The CancerLinQ® Ambassadors Program is an initiative to provide guidance to practices participating in CancerLinQ®.
The CancerLinQ® Ambassadors Program is an initiative to provide guidance to practices participating in CancerLinQ®.

CancerLinQ LLC, a subsidiary of the American Society of Clinical Oncology (ASCO), in collaboration with the Oncology Nursing Society (ONS) has launched a new program called the CancerLinQ® Ambassadors Program.1

CancerLinQ is a database created by oncologists for oncologists, containing large amounts of real world cancer data including patient medical records that can be useful for identifying trends among patients and uncovering patterns that can improve health care.

The CancerLinQ® Ambassadors Program is an engagement initiative to provide real world support and guidance to practices participating in CancerLinQ® on a regional basis. ONS will select nurses with experience in quality improvement, informatics, and technology to serve as ambassadors. These nurses will visit participating practices on a regular basis to address questions and provide training to oncologists, oncology nurses, and their staff. The ambassadors will work with practices to optimize the quality of data provided to CancerLinQ and integrate CancerLinQ into their workflow. They will also bring back first-hand observations and user feedback to CancerLinQ to improve user experience.

“As CancerLinQ continues to engage the community, the need to bring together physicians, nurses and the various professionals of the care team together to leverage our respective strengths is increasingly evident,” said Kevin Fitzpatrick, chief executive officer of CancerLinQ LLC. “We are grateful to work with ONS to build on this commitment to care and enable every practice to get the most out of their use of the CancerLinQ® platform to ultimately benefit patients.”

Brenda Nevidjon, PhD, RN, AOCN®, FAAN, chief executive officer of ONS echoed these sentiments. “Nurses play a critical role in not only the delivery of patient care, but also ensuring that information and data is utilized correctly for quality improvement. This collaboration with CancerLinQ allows nurses, physicians, and the entire health care team to better engage in practice and use technology to improve efficiency and provide the best care possible.”

Reference

1. Leading oncology professional societies launch CancerLinQ® Ambassadors Program [news release]. Alexandria, VA: American Society of Clinical Oncology; March 8, 2017. https://www.ons.org/newsroom/news?field_news_category_value=pr. Accessed March 16, 2017.

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs